Regeneron Pharmaceuticals today announced financial results for the fourth quarter and full year 2024 and provided a business ...

Uvax Bio, a privately held vaccine developer founded in 2018 as a spin-off from Scripps Research, has appointed chief ...

Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Johnson & Johnson (NYSE: JNJ) has gone big early doors this year in the world of pharma M&A. The US healthcare giant ...

Eleva, a German biopharmaceutical company, and 3PBIOVIAN, a global contract development and manufacturing organization (CDMO) ...

German biotech Akribion Therapeutics has emerged from stealth with 8 million euros ($9 million) in seed funding to accelerate ...

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only ...

Russia is experiencing a sharp growth in the demand for drugs against diabetes this year, particular those that are also used ...

US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional ...

French drugmaker Mitem Pharma, which is dedicated to drugs of major therapeutic interest (DMTI), today revealed that has ...

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...